FURIEX PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/cdeaf5fe-3b07-4dbb-b528-4021d78e11c7/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-24.4M | 2013-01-01 – 2013-12-31 | evidence 0001437749-14-004302 |
| FY 2012 | $-40.3M | 2012-01-01 – 2012-12-31 | evidence 0001437749-13-003083 |
| FY 2011 | $-48.6M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-101186 |
| FY 2010 | $-49.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-101186 |
| FY 2009 | $-8.3M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-101186 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FURIEX PHARMACEUTICALS, INC. — all facts · Revenue · Net Income